TrialJournal of immunotherapy (Hagerstown, Md. : 1997)

DNA vaccine encoding prostatic acid phosphatase (PAP) elicits long-term T-cell responses in patients with recurrent prostate cancer.

Jordan T Becker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.